Drug Profile

Lidocaine/prilocaine gel

Alternative Names: Oraqix

Latest Information Update: 07 Feb 2019

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator DENTSPLY International
Class Acetanilides; Anilides; Class Ib antiarrhythmics; Erectile dysfunction therapies; Local anaesthetics; Non-opioid analgesics; Small molecules
Mechanism of Action Opioid receptor agonists; Sodium channel antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Dental pain

Most Recent Events

07 Feb 2019 Chemical structure information added
14 Oct 2004 DENTSPLY has entered into an exclusive distribution agreement with OraPharma for the sale of ldocaine/prilocaine gel in USA
14 Oct 2004 Launched for Dental pain in USA (Topical)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com